HSP70 Expression Signature in Renal Cell Carcinoma: A Clinical and Bioinformatic Analysis Approach

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Heat shock proteins (HSPs) are known for their cytoprotective roles under cellular stress.
• HSP70 has been hypothesized to contribute to increased cancer cell survival.
• Renal cell carcinoma (RCC) is a significant health concern with varied prognoses.

Purpose of the Study:

• To investigate the gene expression signature of HSP70 (HSPA4) in RCC patients.
• To correlate HSP70 expression with clinicopathological features including cancer subtype, stage, grade, and recurrence.
• To combine clinicopathological analysis with in silico approaches for comprehensive validation.

Main Methods:

• Quantitative Real-Time Polymerase Chain Reaction (TaqMan) was used to analyze HSP70 expression in 130 RCC and paired non-cancerous tissue samples.
• Clinicopathological data from patients were correlated with HSP70 expression levels.
• In silico analysis was performed for validation of gene expression findings.

Main Results:

• Upregulated HSP70 (HSPA4) gene expression was observed in RCC tissues compared to non-cancerous tissues.
• HSP70 expression positively correlated with tumor size, grade, capsule infiltration, and recurrence.
• A significant negative correlation was found between HSP70 levels and overall survival (r = -0.87, p < 0.001).

Conclusions:

• HSP70 expression is significantly upregulated in RCC.
• Elevated HSP70 levels are associated with adverse prognostic factors in RCC, including advanced grade, capsule infiltration, and recurrence.
• HSP70 serves as a potential biomarker for poor prognosis and reduced survival in renal cell carcinoma patients.